Topic Hub
6 clinically reviewed articles, written and peer-reviewed by the HealthRX Medical Team.
Explore
Showing 6 of 6 clinical reviews.
A deep-dive into the methodological limitations, enrollment biases, statistical caveats, and generalizability gaps of the TRAVERSE Bone Fracture Substudy that reported a 43% increase in fractures with testosterone therapy.
Read clinical reviewHealth-economic analysis of the TRAVERSE bone fracture substudy: cost per QALY modeling, payer-coverage shifts after a 43% fracture increase signal, and the value calculation for older men considering TRT.
Read clinical reviewDeep-dive into the TRAVERSE bone fracture substudy's long-term follow-up findings, the 43% fracture increase signal with testosterone, durability of harm, and post-trial implications for TRT prescribing in older men.
Read clinical reviewDeep-dive into the TRAVERSE bone fracture substudy results showing a 43% increase in fractures with testosterone replacement therapy in older men, including effect sizes, confidence intervals, subgroup analyses, and time-course patterns.
Read clinical reviewDetailed breakdown of pre-specified and post-hoc subgroup analyses from the TRAVERSE Bone Fracture Substudy, examining which older hypogonadal men faced the greatest fracture risk increase with testosterone replacement therapy.
Read clinical reviewDeep-dive into the TRAVERSE Bone Fracture Substudy showing 43% more fractures with testosterone in older men, and what this means for TRT prescribing, guidelines, and patient selection today.
Read clinical review